Leishmaniasis, Mucocutaneous clinical trials

The registry lists 21 studies for Leishmaniasis, Mucocutaneous across 6 countries. 7 are recruiting or about to start. 16 of them are mainly about Leishmaniasis, Mucocutaneous (how this is decided). Per ClinicalTrials.gov, last updated 2026-10-29.

Get an email when these change. Save the Leishmaniasis, Mucocutaneous studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies

See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed: 11
Recruiting: 5
Not yet recruiting: 2
Status unknown: 2
No longer available: 1

Phase

Phase 2: 12
Phase 3: 6
Phase 1: 4

Where

Brazil: 7
Bolivia: 6
United States: 3
Colombia: 2
Peru: 1
Italy: 1

Who runs them

Fundacion Nacional de Dermatologia (4) · Hospital Universitário Professor Edgard Santos (4) · Knight Therapeutics (USA) Inc (3) · Access to Advanced Health Institute (AAHI) (1) · Meyer Children's Hospital IRCCS (1) · University of California, San Francisco (1) · Universidad Industrial de Santander (1) · University of Brasilia (1)

What is being tested here

Drugs under test in Leishmaniasis, Mucocutaneous studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug	Open	Phase 3	All
Miltefosine	3	2	6
Liposomal amphotericin B	1	1	2
Amphotericin B	1	1	2
Tofacitinib	1	1	1
Pentoxifylline	1	1	1
Paromomycin	0	2	2
Meglumine Antimoniate	0	1	1

Coming up

3phase 3 studies under way

1study finishes main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The study

Nov 2027Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine · Fundacion Nacional de Dermatologia

Who these studies take

Of the 5 Leishmaniasis, Mucocutaneous studies recruiting now, 2 (40%) set no upper age limit and 2 (40%) stop at 75 or younger. 4 (80%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.

Recruiting studies that take each age, of 5
Age	Women	Men
10	2 (40%)	2 (40%)
18	3 (60%)	3 (60%)
30	3 (60%)	3 (60%)
40	3 (60%)	3 (60%)
50	4 (80%)	4 (80%)
65	4 (80%)	4 (80%)
75	3 (60%)	3 (60%)
85	3 (60%)	3 (60%)

Across all 21 studies, recruiting or not: 48% stop at 75 or younger and 48% at 65; 43% take children; 0% are for women only and 5% for men only; 0% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

Studies

Recruiting first, then most recently updated. Showing 21 of 21. search them.